missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD268 (BAFF Receptor) Polyclonal Antibody

Goat Polyclonal Antibody
Brand: Invitrogen™ PA547126
This item is not returnable.
View return policy
Description
In sandwich ELISAs, less than 0.2% cross-reactivity with recombinant human BAFF R is observed. Reconstitute at 0.2 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
Tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), also known as BAFFR, is a protein in humans is encoded by the TNFRSF13C gene. The BAFFR gene is mapped to chromosome 22q13. 1-q13. 31. It has got 184 amino acid transmembrane protein which is 56% identical to the mouse protein. B cell-activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. BAFF plays a crucial role in B cell development and can function through receptors other than BCMA.
Specifications
| CD268 (BAFF Receptor) | |
| Polyclonal | |
| Unconjugated | |
| TNFRSF13C | |
| 2010006P15Rik; B cell-activating factor receptor; BAFF receptor; BAFFR; BAFF-R; B-cell maturation defect; B-cell maturation defect 1; B-cell-activating factor receptor; Bcmd; Bcmd1; Bcmd-1; BLyS receptor 3; BR3; BROMIX; CD268; CVID4; Lvis22; prolixin; RGD1560810; TNF receptor superfamily member 13C; Tnfrsf13c; Tumor necrosis factor receptor superfamily member 13C; tumor necrosis factor receptor superfamily, member 13C | |
| Goat | |
| Antigen affinity chromatography | |
| RUO | |
| 72049 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
| ELISA, Neutralization, Western Blot | |
| 0.2 mg/mL | |
| PBS with 5% trehalose and No Preservative | |
| Q9D8D0 | |
| TNFRSF13C | |
| Mouse myeloma cell line NS0-derived recombinant mouse BAFF R Ser10-Ala71. | |
| 100 μg | |
| Primary | |
| Mouse | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction